Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Pharmaceutical Market Trends, 2007 - 2011
2.
Primary Brain Cancer
3.
AMD Market Outlook to 2012
4.
Drug Delivery Global Industry Guide
5.
21 CFR Part 11 course
6.
Decoding Big Pharmas R&D Strategy in Oncology
7.
Advertising on BioPortfolio
8.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
9.
BioNewsCast Press Release Distribution Service
10.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
Deal Making in the New Healthcare Landscape
This unique report examines issues that are vitally important for establishing realistic market estimates based on the latest P&R insights. This report will show companies how to effectively integrate P&R considerations into the deal making process in order to achieve a significant competitive advantage.
Topics covered include:
> Deal making as an essential pharmaceutical business model
> Developing the best valuation approach
> The changes in today's P&R environment
> Integrating P & R considerations in the deal making process
> Integration of P&R considerations in the valuation process - what to look out for when negotiating a deal
> The impact of integrating P&R considerations in deal making and the drug delivery industry
Table of Contents
Price: $2,900.00 / GBP1,450.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.